Results 21 to 30 of about 38,177 (201)

Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. [PDF]

open access: yesPLoS ONE, 2012
Increasing evidence has pointed to an important role of SUMOylation in cell cycle regulation, especially for M phase. In the current studies, we have obtained evidence through in vitro studies that the master M phase regulator CDK1/cyclin B kinase ...
Yee-Fun Su   +4 more
doaj   +1 more source

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma

open access: yesFrontiers in Cell and Developmental Biology, 2023
Background: Recent studies have revealed that SUMOylation modifications are involved in various biological processes, including cancer development and progression.
Zhike Chen   +18 more
doaj   +1 more source

Analysis of human cytomegalovirus-encoded SUMO targets and temporal regulation of SUMOylation of the immediate-early proteins IE1 and IE2 during infection. [PDF]

open access: yesPLoS ONE, 2014
Post-translational modification of proteins by members of the small ubiquitin-like modifier (SUMO) is involved in diverse cellular functions. Many viral proteins are SUMO targets and also interact with the cellular SUMOylation system.
Eui Tae Kim   +5 more
doaj   +1 more source

FTSJ3‐Mediated 2′‐O‐Methylation of HSPA5 mRNA Stabilizes BOP1 via SUMOylation to Drive DRP1‐Dependent Mitochondrial Fission and Fatty Acid Oxidation in Lung Squamous Cell Carcinoma [PDF]

open access: yesAdvanced science
The RNA methyltransferase FTSJ3 drives lung squamous cell carcinoma progression by catalyzing 2′‐O‐methylation of HSPA5 mRNA, which stabilizes BOP1 through SUMOylation and activates DRP1/SREBP1‐mediated mitochondrial fission and fatty acid oxidation. Targeting this axis with liposomal siRNA potently suppresses tumor growth and metastasis ABSTRACT Lung ...
Hu Q, Lin J, Zhu Y, Liu Y, Zhou G.
europepmc   +2 more sources

Natural Products Against Renal Fibrosis via Modulation of SUMOylation

open access: yesFrontiers in Pharmacology, 2022
Renal fibrosis is the common and final pathological process of kidney diseases. As a dynamic and reversible post-translational modification, SUMOylation and deSUMOylation of transcriptional factors and key mediators significantly affect the development ...
Peng Liu   +5 more
doaj   +1 more source

Sumoylation of Hes6 Regulates Protein Degradation and Hes1-Mediated Transcription [PDF]

open access: yesEndocrinology and Metabolism, 2015
BackgroundHes6 is a transcriptional regulator that induces transcriptional activation by binding to transcription repressor Hes1 and suppressing its activity. Hes6 is controlled by the ubiquitin-proteosome-mediated degradation system.
Jiwon Lee   +3 more
doaj   +1 more source

Perturbation of maternal PIASy abundance disrupts zygotic genome activation and embryonic development via SUMOylation pathway

open access: yesBiology Open, 2019
During the maternal-to-zygotic transition (MZT), mRNAs and proteins stored in oocytes are degraded and zygotic genes are activated. We have previously shown that the ubiquitin-proteasome system (UPS)-mediated degradation of maternal proteins plays a role
Chika Higuchi   +4 more
doaj   +1 more source

A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver

open access: yeseLife, 2015
SUMO-modification of nuclear proteins has profound effects on gene expression. However, non-toxic chemical tools that modulate sumoylation in cells are lacking. Here, to identify small molecule sumoylation inhibitors we developed a cell-based screen that
Miyuki Suzawa   +12 more
doaj   +1 more source

SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2. [PDF]

open access: yesPLoS ONE, 2012
Nanog is a pivotal transcription factor in embryonic stem (ES) cells and is essential for maintaining the pluripotency and self-renewal of ES cells. SUMOylation has been proved to regulate several stem cell markers' function, such as Oct4 and Sox2. Nanog
Yongyan Wu   +10 more
doaj   +1 more source

Post-translational Regulation of GLT-1 in Neurological Diseases and Its Potential as an Effective Therapeutic Target

open access: yesFrontiers in Molecular Neuroscience, 2019
Glutamate transporter-1 (GLT-1) is a Na+-dependent transporter that plays a key role in glutamate homeostasis by removing excess glutamate in the central nervous system (CNS).
Allison R. Peterson, Devin K. Binder
doaj   +1 more source

Home - About - Disclaimer - Privacy